Skip to content

Effects of azitromycin on Hospitalized Infants With Acute Bronchiolitis: A Randomized, prospective, double-blind, placebo-controlled study.

Effects of azitromycin on length of hospital stay in Infants With Acute Bronchiolitis: A Randomized, prospective, double-blind, placebo-controlled study.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609001031257
Enrollment
84
Registered
2009-11-30
Start date
2009-03-10
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of the study is evaluate the efficacy of azitromycin (a drug) in infants less than 7 months of age with acute viral bronchiolitis, by reducing the length of hospital stay.

Interventions

Azitromycin - oral syrup Dose 10mg/kg/day - oral 7 days

Sponsors

Universidade Federal do Rio Grande do Sul
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
10 Days to 7 Months
Healthy volunteers
No

Inclusion criteria

Infants less than 7 months of age who were admitted to Hospital de Clínicas de Porto Alegre between March 2009 and July 2010 with a first episode of wheezing requiring hospitalization and supplemental oxygen, with a clinical diagnosis of bronchiolitis

Exclusion criteria

Infants with cardiac, metabolic disease or clinically significant respiratory disease, such as cystic fibrosis, were not eligible, although infants with chronic neonatal lung disease associated with prematurity were included. Infants were excluded if they had received corticosteroids in any form within 7days before presentation or had received macrolides before presentation.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026